GV, Dell Technologies Capital and Salesforce Ventures have all returned to back the digital experience tracking service’s latest round, which valued it at $1.8bn.

Osage University Partners has backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

Alphabet, Eli Lilly, Dong-A ST and Alexandria Real Estate Equities backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

SoftBank Vision Fund 2 took part in the 401(k) plan provider’s latest round that valued the business at $1bn, six months after it closed a series C.

CapitalG helped data science platform Dataiku raise series E capital, which increased the company's valuation to $4.6bn.

The money was split across series A and A-plus rounds and came from investors including Chint and Sinopec.

China Merchants Capital has co-led a series B round sized at almost $99.2m that also attracted existing shareholder Legend Capital.

UC Berkeley’s robotics software developer Covariant hiked its overall funding to $147m in a round led by returning investor Index Ventures.

MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.

4490 Ventures-backed Rentable has received $22.5m in its series B round.